- Report
- April 2025
- 200 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- February 2025
- 200 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- February 2025
- 200 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- February 2025
- 200 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- February 2025
- 200 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- January 2025
- 175 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- December 2024
- 175 Pages
Global
From €4448EUR$5,000USD£3,841GBP
- Report
- July 2025
Global
From €4359EUR$4,900USD£3,764GBP
- Report
- August 2025
- 154 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 200 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 414 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 179 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- April 2025
- 200 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- April 2025
- 200 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- April 2025
- 200 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- April 2025
- 200 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- April 2025
- 200 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- March 2025
- 175 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- March 2025
- 200 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- March 2025
- 250 Pages
Global
From €3995EUR$4,490USD£3,449GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more